Natixis’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-99,206
Closed -$5.13M 1414
2022
Q3
$5.13M Buy
+99,206
New +$4.1M 0.02% 403

Other funds holding CCXI

Natixis's CCXI Position: Q4 2022 in Review

Natixis sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 99,206 shares — an estimated $5.13M sold.

Natixis first reported a position in CCXI in Q3 2022 and held it in 1 quarter. The position peaked at $5.13M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Natixis reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Natixis sold 99,206 ChemoCentryx, Inc. shares in Q4 2022, an estimated $5.13M.
  • Natixis first reported a position in ChemoCentryx, Inc. in Q3 2022 and held it in 1 quarter.
  • Natixis's ChemoCentryx, Inc. position peaked at $5.13M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Natixis's 13F filing for Q4 2022, filed 13 Feb 2023.